Aldo A. Acosta‐Medina

Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on <i>KRAS</i> and <i>MEK</i> Alteration Status

Jithma P. Abeykoon, Karen L. Rech, Jason R. Young et al. · JAMA Oncology · 2022 · 44 citations · Full text

<i>BRAF</i> V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Aldo A. Acosta‐Medina, Paul G. Kemps, Timo C. E. Zondag et al. · Blood · 2023 · 22 citations · Full text

Long-term outcomes among adults with Langerhans cell histiocytosis

Gaurav Goyal, Aldo A. Acosta‐Medina, Jithma P. Abeykoon et al. · Blood Advances · 2023 · 21 citations · Full text

Cell Pathology, Immunodeficiencies, Immunology +20

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Christianne Bourlon, Rocío Camacho-Hernández, Oscar Manuel Fierro-Angulo et al. · Biology of Blood and Marrow Transplantation · 2020 · 19 citations · Full text

Cell Therapy, Latent Tuberculosis, Tuberculosis Prevention +19

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation

Aldo A. Acosta‐Medina, Ann M. Moyer, Ronald S. Go et al. · Blood Advances · 2022 · 16 citations · Full text